The MMADHC gene helps your body use vitamin B12, which cells need for energy, nerve function, and healthy blood cells. If this gene does not work properly, the body may not handle vitamin B12 in the usual way, and a rare inherited condition called cblD can result. People with harmful variants in the MMADHC gene may have poor feeding, slow growth, low muscle tone, developmental delay, vision changes, or anemia. In medicine, this gene is important because its results can help explain these symptoms and guide care.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which are the parts of cells that do much of the work. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this subject, you can read more in the LearnHub.
Overview
MMADHCGene function
What if the gene works
The MMADHC gene helps cells process vitamin B12 into its active forms. These forms support energy production and help recycle homocysteine, an amino acid in the blood.
Risk
What if the gene does not work
Variants in the MMADHC gene can cause cobalamin D disease, leading to methylmalonic acid buildup, high homocysteine, or both. Effects range from milder to more severe, which can influence when symptoms appear and which body systems are affected.
Treatment
What does that mean for your treatment
Pathogenic variants in the MMADHC gene can guide use of hydroxocobalamin, often by regular injection, because many people with cblD related disease benefit from this treatment. Betaine is often added when homocysteine is elevated, and some may also receive folate support or carnitine based on their biochemical pattern. Response varies by the specific MMADHC variant and whether methylmalonic acid, homocysteine, or both are increased.
Conditions associated with MMADHC
Gene function
What if the gene works
In simple terms, MMADHC gene function centers on helping your cells use vitamin B12 in the right place and form. This supports everyday chemical steps that help cells make energy and recycle key building blocks. When this system runs smoothly, vitamin B12 can be routed to the cell areas that need it most.
The MMADHC gene helps cells process vitamin B12 after it enters the body. Its protein acts like an internal guide so this vitamin can be prepared for active use inside cells.
This gene helps send vitamin B12 into two main working routes inside the cell. That routing lets the vitamin be changed into the forms needed in the cell fluid and in mitochondria (the parts of cells that make energy).
One active form of vitamin B12 supports a pathway that helps break down certain fats and proteins for energy. MMADHC helps supply that form where cells need it for steady day to day metabolism.
Another active form of vitamin B12 helps cells recycle homocysteine into methionine, a building block used across the body. By supporting this route, the MMADHC gene helps with routine cell growth and chemical balance.
What is a variant?
Genetic variants are small differences in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MMADHC gene can alter how cells process vitamin B12 by shortening the protein, making it unstable, or changing the parts that guide it to different cell pathways. This helps explain how MMADHC variants affect vitamin B12 metabolism. Milder variants may leave some activity, while more severe variants can greatly reduce or stop it. That difference can shape whether cblD features are more limited or appear earlier and involve both methylmalonic acid buildup and homocysteine buildup.
How variants are linked to conditions
Pathogenic variants in the MMADHC gene cause a rare inherited cobalamin metabolism condition called cblD, and MMADHC gene variants are linked to homocystinuria, methylmalonic acidemia, or both together. People with this diagnosis may have feeding difficulties, low energy, developmental delay, or blood and nerve problems, although symptoms vary. A confirmed MMADHC-related finding helps explain the condition rather than simply pointing to a higher chance of it.
A variant is not necessarily a diagnosis
Variants in genes are a common and normal feature of human biology. Most do not directly affect health and are simply one part of natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when more than one gene and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For MMADHC, risk is mainly set by inheritance: a child is affected when they inherit nonworking copies from both parents. Family history and whether both parents carry an MMADHC change are the main factors that change the chance for a pregnancy. There is not enough evidence to say that lifestyle or environmental factors meaningfully lower this genetic risk.
Inheritance of MMADHC variants
Variants in the MMADHC gene are inherited in an autosomal recessive pattern. This means a person usually develops an MMADHC-related condition only when they inherit two changed copies of the gene, one from each parent. Parents who each carry one variant are often unaffected carriers. With this MMADHC inheritance pattern, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child with two working copies.
What does my MMADHC result mean for my family?
For families of people with a disease-causing change in the MMADHC gene, the pattern is usually recessive, which means close relatives may also be carriers even if they feel completely well. Brothers and sisters could have the same condition or be carriers, depending on which gene changes they inherited. Parents are usually healthy carriers, and other blood relatives may also carry the same gene change in the family.
Genetic information
Genetic testing
How you find out about variants
To find out about changes in this gene, genetic testing for MMADHC variants reads the MMADHC gene from a blood sample, cheek swab, or saliva sample. A lab looks for variants that may explain symptoms or family history, and results can show a disease-causing variant, no relevant variant, or a result that remains uncertain.
When should I consider getting a genetic test?
Consider testing the MMADHC gene if a baby, child, or adult has signs of a rare condition that makes it hard for the body to use vitamin B12, or if newborn screening or blood and urine tests raise concern. Testing can also help when this condition runs in the family or a relative has a known MMADHC variant.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much clarity they provide varies by the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, these results can help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, cause more side effects in another, or seem less effective for someone else. These differences are common and are one part of why medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies patterns between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more personalized. You can explore this topic in more detail in the LearnHub.
Drugs influenced by the MMADHC gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines, so medication questions, side effects, or new symptoms are best discussed with your doctor. They can review your full health history and current treatments to decide what matters most for your care.
History
MMADHC entered medical genetics through studies of rare inherited problems in vitamin B12 processing, especially the cblD type of methylmalonic aciduria and homocystinuria. Families and communities once noticed patterns that seemed to pass from parent to child, but the genetic cause became clear only in the 2000s. Researchers identified the MMADHC gene after comparing affected children with unusual biochemical findings and tracing the shared inherited change. This discovery helped explain why some people had mainly methylmalonic acid buildup, some had homocystinuria, and others had both. From these first observations, research expanded steadily, linking different MMADHC variants with different clinical patterns and improving genetic diagnosis for families.